REFERENCES
- Ader R., Felten D., Cohen N. Interactions between the brain and the immune system. Ann. Rev. Pharmacol. Toxicol. 1990; 30: 561–602, [CSA]
- Straub R.H., Westermann J., Scholmerich J., Falk W. Dialogue between the CNS and the immune system in lymphoid organs. Immunol. Today 1998; 19: 409–413, [INFOTRIEVE], [CSA], [CROSSREF]
- Rabin B.S. Stress, Immune Function, and Health: The Connection. John Wiley and Sons. 1999
- Downing J.E., Miyan J.A. Neural immunoregulation: emerging roles for nerves in immune homeostasis and disease. Immunol. Today 2000; 21: 281–289, [INFOTRIEVE], [CSA], [CROSSREF]
- Russo-Marie F. Macrophages and the glucorticoids. J. Neuroimmunol. 1992; 40: 281–286, [INFOTRIEVE], [CSA], [CROSSREF]
- Ashwell J.D., Lu F.W., Vecchio M.S. Glucocorticoids in T cell development and function. Ann. Rev. Immunol. 2000; 18: 309–345, [CSA], [CROSSREF]
- Madden K.S. Catecholamines, sympathetic innervation, and immunity. Brain Behav. Immun. 2003; 17(1)S5–10, [INFOTRIEVE], [CSA], [CROSSREF]
- Guerriero J.M., Reiter R.J. Melatonin-immune system relationships. Curr. Top. Med. Chem. 2002; 2: 167–179, [CSA], [CROSSREF]
- Inui A. Cytokines and sickness behavior: implications from knockout animal models. Trends Immunol. 2001; 22: 469–473, [INFOTRIEVE], [CSA], [CROSSREF]
- Locati M., Murphy P.M. Chemokines and chemokine receptors: biology and clinical relevance in inflammation and AIDS. Ann. Rev. Med. 1999; 50: 425–440, [INFOTRIEVE], [CSA], [CROSSREF]
- Zhang N., Oppenheim J.J. Cross-talk between chemokines and neuronal receptors bridges immune and nervous systems. J. Leukoc. Biol. 2005; 78: 1210–1214, [INFOTRIEVE], [CSA], [CROSSREF]
- Adler M.W., Rogers T.J. Are chemokines the third major system in the brain?. J. Leukoc. Biol. 2005; 78: 1204–1209, [INFOTRIEVE], [CSA], [CROSSREF]
- Hickey W.F., Hsu B.L., Kimura H. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 1991; 129: 51–57, [CSA]
- Moore C.B., Siopes T.D. Melatonin enhances cellular and humoral immune responses in the Japanese quail (Coturnix coturnix japonica) via an opiatergic mechanism. Gen. Comp. Endocrinol. 2003; 131: 258–263, [INFOTRIEVE], [CSA], [CROSSREF]
- Garcia-Maurino S., Gonzalez-Haba M.G., Calvo J.R., Rafii-El-Idrissi M., Sanchez-Margalet V., et al. Melatonin enhances IL-2, IL-6, and IFN-gamma production by human circulating CD4+ cells: a possibile nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes. J. Immunol. 1997; 159: 574–581, [INFOTRIEVE], [CSA]
- Prod'homme T., Weber M.S., Steinman L., Zamvil S.S. A neuropeptide in immune-mediated inflammation, Y?. Trends Immunol. 2006; 27: 164–167, [INFOTRIEVE], [CSA], [CROSSREF]
- Yao J.H., Ye S.M., Burgess W., Zachary J.F., Kelly K.W., Johnson R.W. Mice deficient in interleukin-1beta converting enzyme resist anorexia induced by central lipopolysaccharide. Am. J. Physiol. 1999; 277: R1435–1443, [INFOTRIEVE], [CSA]
- Luheshi G.N., Gardner J.D., Rushforth D.A., Loudon A.S., Rothwell N.J. Leptin actions on food intake and body temperature are mediated by IL-1. Proc. Natl. Acad. Sci. USA 1999; 96: 7047–7052, [INFOTRIEVE], [CSA], [CROSSREF]
- Dinarello C.A. Infection, fever, and exogenous and andogenous pyrogens: some concepts have changed. J. Endotoxin. Res. 2004; 10: 201–222, [INFOTRIEVE], [CSA], [CROSSREF]
- Kozak W., Kluger M.J., Soszynski D., Conn C.A., Rudolph K., et al. IL-6 and IL-1 beta in fever. Studies using cytokine-deficient (knockout) mice. Ann. N. Y. Acad. Sci. 1998; 856: 33–47, [INFOTRIEVE], [CSA], [CROSSREF]
- Fang J., Wang Y., Krueger J.M. Mice lacking the TNF 55 kDa receptor fail to sleep more after TNF alpha treatment. J. Neurosci. 1997; 17: 5949–5955, [INFOTRIEVE], [CSA]
- Alleva E., Citrulli F., Bianchi M., Bondiolotti G.P., Chiaretti F., et al. Behavioural characterization of interleukin-6 overexpressing or deficient mice during agonistic encounters. Eur. J. Neurosci. 1998; 10: 3664–3672, [INFOTRIEVE], [CSA], [CROSSREF]
- Petitto J.M., McNamara R.K., Gendreau P.L., Huang Z., Jackson A.J. Impaired learning and memory and altered hippocampal neurodevelopment resulting from interleukin-2 gene deletion. J. Neurosci. Res. 1999; 56: 441–446, [INFOTRIEVE], [CSA], [CROSSREF]
- Rittner H.L., Machelska H., Stein C. Leukocytes in the regulation of pain and analgesia. J. Leukoc. Biol. 2005; 78: 1215–1222, [INFOTRIEVE], [CSA], [CROSSREF]
- Li Y., Ji A., Weihe E., Schafer M.K. Cell-specific expression and lipopolysaccharide-induced regulation of tumor necrosis factor alpha (TNF alpha) and TNF receptors in rat dorsal root ganglion. J. Neurosci. 2004; 24: 9623–9631, [INFOTRIEVE], [CSA], [CROSSREF]
- Schäfers M., Sorkin L.S., Geis C., Shubayev V.I. Spinal nerve ligation induced transient upregulation of tumor necrosis factor receptors 1 and 2 in injured and adjacent uninjured dorsal root ganglia in the rat. Neurosci. Lett. 2003; 347: 179–182, [CSA]
- Cunha F.Q., Ferreira S.H. Peripheral hyperalgesic cytokines. Adv. Exp. Med. Biol. 2003; 52: 22–39, [CSA]
- Woolf C.J., Allchorne A., Safieh-Garabedian B., Poole S. Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br. J. Pharmacol. 1997; 121: 417–424, [INFOTRIEVE], [CSA], [CROSSREF]
- Sommer C., Petrausch S., Lindenlaub T., Toyka K.V. Neutralizing antibodies to interleukin 1-receptor reduce pain associated behavior in mice with experimental neuropathy. Neurosci. Lett. 1999; 270: 25–28, [INFOTRIEVE], [CSA], [CROSSREF]
- Opree A., Kress M. Involvement of the proinflammatory cytokines tumor necrosis factor-alpha, IL-1 beta, and IL-6 but not IL-8 in the development of heat hyperalgesia: effects on heat-evoked calcitonin gene-related peptide release from rat skin. J. Neurosci. 2000; 20: 6289–6293, [INFOTRIEVE], [CSA]
- Obreja O., Schmelz M., Poole S., Kress M. Interleukin-6 in combination with its soluble IL-6 receptor sensitizes rat skin nociceptors to heat in vivo. Pain 1999; 96: 57–62, [CSA], [CROSSREF]
- Xu X.J., Hao J.X., Andell-Jonsson S., Poli V., Bartfai T., Wiesenfeld-Hallin Z. Nociceptive responses in interleukin-6-deficient mice to peripheral inflammation and peripheral nerve section. Cytokine 1997; 9: 1028–1033, [INFOTRIEVE], [CSA], [CROSSREF]
- Zalavary S., Bengtsson T. Adenosine inhibits actin dynamics in human neutrophils: evidence for the involvement of cAMP. Eur. J. Cell. Biol. 1998; 75: 128–139, [INFOTRIEVE], [CSA]
- Spisani S., Pareschi M.C., Buzzi M., Colamussi M.L., Biondi C., et al. Effect of cyclic AMP level reduction on human neutrophil responses to formylated peptides. Cell. Signal. 1996; 8: 269–277, [INFOTRIEVE], [CSA], [CROSSREF]
- Ledent C., Vaugeois J.M., Schiffmann S.N., Pedrazzini T., El Yacoabi M., et al. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 1997; 388: 674–678, [INFOTRIEVE], [CSA], [CROSSREF]
- Lewin G.R., Rueff A., Mendell L.M. Peripheral and central mechanisms of NGF-induced hyperalgesia. Eur. J. Neurosci. 1994; 6: 1903–1912, [INFOTRIEVE], [CSA], [CROSSREF]
- Ro L.S., Chen S.T., Tang L.M., Jacobs J.M. Effect of NGF and anti-NGF on neuropathic pain in rats following chronic constriction injury of the sciatic nerve. Pain. 1999; 79: 265–274, [INFOTRIEVE], [CSA], [CROSSREF]
- Kieffer B.L., Gaveriaux-Ruff C. Exploring the opioid system by gene knockout. Prog. Neurobiol. 2002; 66: 285–306, [CSA], [CROSSREF]
- Stein C., Schafer M., Machelska H. Attacking pain at its source: new perspectives on opioids. Nat. Med. 2003; 9: 1003–1008, [INFOTRIEVE], [CSA], [CROSSREF]
- Machelska H., Stein C. Immune mechanisms in pain control. Anesth. Analg. 2002; 95: 1002–1008, [INFOTRIEVE], [CSA], [CROSSREF]
- Binder W., Mousa S.A., Sitte N., Kaiser M., Stein C., Schafer M. Sympathetic activation triggers endogenous opioid release and analgesia within peripheral inflamed tissue. Eur. J. Neurosci. 2004; 20: 92–100, [INFOTRIEVE], [CSA], [CROSSREF]
- Covelli V., Passeri M.E., Leogrande D., Jirillo E., Amati L. Drug targets in stress-related disorders. Curr. Med. Chem. 2005; 12: 763–771, [CSA], [CROSSREF]
- Glaser R., MacCallum R.C., Laskowski B.F., Malarkey W.B., Sheridan J.F., Kiecolt-Glaser J.K. Evidence for a shift in the Th-1 to Th-2 cytokine response associated with chronic stress and aging. J. Gerontol. A. Biol. Sci. Med. Sci. 2001; 56: M477–M482, [INFOTRIEVE], [CSA]
- Teunis M.A., Heijnen C.J., Sluyter F., Bakker J.M., Van Dam A.M., et al. Maternal deprivation of rat pups increases clinical symptoms of experimental autoimmune encephalomyelitis at adult age. J. Neuroimmunol. 2002; 133: 30–38, [INFOTRIEVE], [CSA], [CROSSREF]
- Gerrity T.R., Papanicolaou D.A., Amsterdam J.D., Bingham S., Grossman A., et al. CFIDS Association of America. Immunologic aspects of chronic fatigue syndrome. Report on a research symposium convened by CFIDS Association of America and cosponsored by the U.S. Centers for Disease Control and Prevention and the National Institutes of Health. Neuroimmunomodulation 2004; 11: 351–357, [INFOTRIEVE], [CSA], [CROSSREF]
- Staines D.R. Is chronic fatigue syndrome an autoimmune disorder of endogenous neuropeptides, exogenous infection and molecular mimicry?. Med. Hypotheses 2004; 62: 646–652, [INFOTRIEVE], [CSA], [CROSSREF]
- Vollmer-Conna U., Cloyd A., Hickie I., Wakefield D. Chronic fatigue syndrome: an immunological perspective. Aust. NZJ. Psych. 1998; 32: 523–527, [CSA], [CROSSREF]
- Cleare A.J., O'Keane V., Miell J. Plasma leptin in chronic fatigue syndrome and a placebo-controlled study of the effects of low-dose hydrocortisone on leptin secretion. Clin. Endocrinol. 2001; 55: 113–119, [CSA], [CROSSREF]
- Faden A.I. Experimental neurobiology of central nervous system trauma. Crit. Rev. Neurobiol. 1993; 7: 175–186, [INFOTRIEVE], [CSA]
- Franzen R., Schoenen J., Leprince P., Joosten E., Moonen G., Martin D. Effects of macrophage transplantation in the injured adult rat spinal cord: a combined immunocytochemical and biochemical study. J. Neurosci. Res. 1998; 51: 316–327, [INFOTRIEVE], [CSA], [CROSSREF]
- Lindholm D., Heumann R., Meyer M., Thoenen H. Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature 1987; 330: 658–659, [INFOTRIEVE], [CSA], [CROSSREF]
- Stoll G., Trapp B.D., Griffin J.W. Macrophage function during Wallerian degeneration of rat optic nerve: clearance of degenerating myelin and Ia expression. J. Neurosci. 1989; 9: 2327–2335, [INFOTRIEVE], [CSA]
- Popovich P.G., Guan Z., Wei P., Huitinga I., van Rooijen N., Stokes B.T. Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp. Neurol. 1999; 158: 351–365, [INFOTRIEVE], [CSA]
- Kipnis J., Yoles E., Schori H., Hauben E., Shaked I., Schwartz M. Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response. J. Neurosci. 2001; 21: 4564–4571, [INFOTRIEVE], [CSA]
- Hailer N.P., Bechmann I., Heizmann S., Nitsch R. Adhesion molecule expression on phagocytic microglial cells following anterograde degeneration of perforant path axons. Hippocampus 1997; 263: 16348–16351, [CSA]
- de Castro R., Jr., Hughes M.G., Xu G.Y., Clifton C., Calingasan N.Y., et al. Evidence that infiltrating neutrophils do not release reactive oxygen species in the site of spinal cord injury. Exp. Neurol. 2004; 190: 414–424, [INFOTRIEVE], [CSA], [CROSSREF]
- Schwartz M. Immunological approaches to the treatment of spinal cord injury. Biodrugs 2001; 15: 585–593, [INFOTRIEVE], [CSA], [CROSSREF]
- Hauben E., Gothilf A., Cohen A., Butovsky O., Nevo U. Vaccination with dendritic cells pulsed with peptides of myelin basic protein promotes functional recovery from spinal cord injury. J. Neurosci. 2003; 23: 8808–8819, [INFOTRIEVE], [CSA]
- Markley K., Smallman E.T. Effect of thermal trauma on numbers and function of T and B cells from mouse spleen. Int. Arch. Allergy Appl. Immunol. 1977; 54: 238–246, [INFOTRIEVE], [CSA]
- Makarenkova V.P., Bansal V., Matta B.M., Perez L.A., Ochoa J.B. CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress. J. Immunol. 2006; 176: 2085–2094, [INFOTRIEVE], [CSA]
- Quattrocchi K.B., Issel B.W., Miller C.H., Frank E.H., Wagner F.C., Jr. Impairment of helper T-cell function following severe head injury. J. Neurotrauma 1992; 9: 1–9, [INFOTRIEVE], [CSA]
- Popovich P.G., Stuckman S., Gienapp I.E., Whitacre C.C. Alterations in immune cell phenotype and function after experimental spinal cord injury. J. Neurotrauma 2001; 18: 957–966, [INFOTRIEVE], [CSA], [CROSSREF]
- Iversen P.O., Hjeltnes N., Holm B., Flatebø T., Strom-Gundersen I., et al. Depressed immunity and impaired proliferation of hematopoietic progenitor cells in patients with complete spinal cord injury. Blood 2000; 96: 2081–2083, [INFOTRIEVE], [CSA]
- Pan S.C., Hsieh S.M., Wang Y.H., Chiang B.L., Huang T.S., Chang S.C. In vitro maturation potential of monocyte-derived dendritic cells is impaired in patients with spinal cord injury: a case-control study. Arch. Phys. Med. Rehabil. 2005; 86: 974–978, [INFOTRIEVE], [CSA], [CROSSREF]
- Watkins L.R., Maier S.F. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol. Rev. 2002; 82: 981–1011, [INFOTRIEVE], [CSA]
- Johnson D., Weiner H.L., Seeldrayers P.A. Role of mast cells in peripheral nervous system demyelination. Ann. NY Acad. Sci. 1988; 540: 727–728, [INFOTRIEVE], [CSA]
- Wekerle H., Schwab M., Linington C., Meyermann R. Antigen presentation in the peripheral nervous system: Schwann cells present endogenous myelin autoantigens to lymphocytes. Eur. J. Immunol. 1986; 16: 1551–1557, [INFOTRIEVE], [CSA]
- Kagan B.L., Baldwin R.L., Munoz D., Wisnieski B.J. Formation of ion-permeable channels by tumor necrosis factor-alpha. Science 1992; 255: 1427–1430, [INFOTRIEVE], [CSA], [CROSSREF]
- Wilkinson M.F., Earle M.L., Triggle C.R., Barnes S. Interleukin-1beta, tumor necrosis factor-alpha, and LPS enhance calcium channel current in isolated vascular smooth muscle cells of rat tail artery. FASEB J. 1996; 10: 785–791, [INFOTRIEVE], [CSA]
- Schoeniger D., Twining C., Milligan D., Martino D., Pattey C., et al. Peri-sciatic proinflammatory cytokines mediate allodynia produced by sciatic inflammatory neuropathy (SIN). Proc. Soc. Neurosci. 2002; 13: 21–23, [CSA]
- Ramer M.S., Murphy P.G., Richardson P.M., Bisby M.A. Spinal nerve lesion-induced mechanoallodynia and adrenergic sprouting in sensory ganglia are attenuated in interleukin-6 knockout mice. Pain. 1998; 78: 115–121, [INFOTRIEVE], [CSA], [CROSSREF]
- Liu T., Knight K.R., Tracey D.J. Hyperalgesia due to nerve injury-role of peroxynitrite. Neuroscience 2000; 97: 125–131, [INFOTRIEVE], [CSA], [CROSSREF]
- Laughlin T.M., Bethea J.R., Yezierski R.P., Wilcox G.L. Cytokine involvement in dynorphin-induced allodynia. Pain. 2000; 84: 159–167, [INFOTRIEVE], [CSA], [CROSSREF]
- Lu P., Jones L.L., Tuszynski M.H. BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury. Exp. Neurol. 2005; 191: 344–360, [INFOTRIEVE], [CSA], [CROSSREF]
- Hayashi Y., Shumsky J.S., Connors T., Otsuka T., Fischer I., et al. Immunosuppression with either cyclosporine A or FK506 supports survival of transplanted fibroblasts and promotes growth of host axons into the transplant after spinal cord injury. J. Neurotrauma 2005; 22: 1267–1281, [INFOTRIEVE], [CSA], [CROSSREF]
- Hauben E., Nevo U., Yoles E., Moalem G., Agranov E., et al. Autoimmune T cells as potential neuroprotective therapy for spinal cord injury. Lancet 2000; 355: 286–287, [INFOTRIEVE], [CSA], [CROSSREF]
- Ibarra A., Hauben E., Butovsky O., Schwartz M. The therapeutic window after spinal cord injury can accommodate T cell-based vaccination and methylprednisolone in rats. Eur. J. Neurosci. 2004; 19: 2984–2990, [INFOTRIEVE], [CSA], [CROSSREF]
- Saville L.R., Pospisil C.H., Mawhinney L.A., Bao F., Simedrea F.C., et al. A monoclonal antibody to CD11d reduces the inflammatory infiltrate into the injured spinal cord: a potential neuroprotective treatment. J. Neuroimmunol. 2004; 156: 42–57, [INFOTRIEVE], [CSA], [CROSSREF]
- Vallières N., Berard J.L., David S., Lacroix S. Systemic injections of lipopolysaccharide accelerates myelin phagocytosis during Wallerian degeneration in the injured mouse spinal cord. Glia 2006; 53: 103–113, [CSA], [CROSSREF]
- Hirose K., Okajima K., Taoka Y., Uchiba M., Tagami H., et al. Activated protein C reduces the ischemia/reperfusion-induced spinal cord injury in rats by inhibiting neutrophil activation. Ann. Surg. 2000; 232: 272–280, [INFOTRIEVE], [CSA], [CROSSREF]
- GrandPré T., Nakamura F., Vartanian T., Strittmatter S.M. Identification of the Nogo inhibitor of axon regeneration as a reticulon protein. Nature 2000; 403: 439–444, [CSA], [CROSSREF]
- Li M., Shibata A., Li C., Braun P.E., McKerracher L., et al. Myelin-associated glycoprotein inhibits neurite/axon growth and causes growth cone collapse. J. Neurosci. Res. 1996; 46: 404–414, [INFOTRIEVE], [CSA], [CROSSREF]
- Schnell L., Schwab M.E. Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature 1990; 343: 269–272, [INFOTRIEVE], [CSA], [CROSSREF]
- Dietrich W.D., Chatzipanteli K., Vitarbo E., Wada K., Kinoshita K. The role of inflammatory processes in the pathophysiology and treatment of brain and spinal cord trauma. Acta Neurochir. 2004; 89: 69–74, [CSA]
- Niederost B.P., Zimmermann D.R., Schwab M.E., Bandtlow C.E. Bovine CNS myelin contains neurite growth-inhibitory activity associated with chondroitin sulfate proteoglycans. J. Neurosci. 1999; 19: 8979–8989, [INFOTRIEVE], [CSA]
- Cadelli D., Schwab M.E. Regeneration of lesioned septo hippocampal acetylcholinesterase-positive axons is improved by antibodies against the myelin-associated neurite growth inhibitors NI-35/250. Eur. J. Neurosci. 1991; 3: 825–832, [INFOTRIEVE], [CSA], [CROSSREF]
- Popovich P.G. Immunological regulation of neuronal degeneration and regeneration in the injured spinal cord. Prog. Brain Res. 2000; 128: 43–58, [INFOTRIEVE], [CSA]
- David S., Ousman S.S. Recruiting the immune response to promote axon regeneration in the injured spinal cord. Neuroscientist 2002; 8: 33–41, [INFOTRIEVE], [CSA]